Real World Treatment Outcomes in Chinese Patients with RET-Rearranged Lung Cancer

被引：0
|
作者：
Yang, L. [1 ]
Liu, Z. [2 ]
Qiu, W. [3 ]
Yang, G. [4 ]
Xu, H. [5 ]
Wang, Y. [4 ]
机构：
[1] Chinese Acad Med Sci & Peking Union Med Coll, Dept Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[2] Chinese Peoples Liberat Army Gen Hosp, Beijing, Peoples R China
[3] Haalthy Inc, Beijing, Peoples R China
[4] Chinese Acad Med Sci & Peking Union Med Coll, Med Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
[5] Chinese Acad Med Sci & Peking Union Med Coll, Dept Comprehens Oncol, Natl Canc Ctr, Natl Clin Res Ctr Canc,Canc Hosp, Beijing, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2019年 / 14卷 / 10期
关键词：
real-world study; non-small-cell lung cancer; RET-rearranged;
D O I：
10.1016/j.jtho.2019.08.1786
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P2.14-01
引用
收藏
页码：S829 / S829
页数：1
相关论文
共 50 条
  • [21] RET-rearranged lung cancers: Immunophenotype and response to immunotherapy.
    Sabari, Joshua K.
    Offin, Michael David
    Wu, Stephanie L.
    Ni, Ai
    Halpenny, Darragh
    Montecalvo, Joseph
    Liu, Dazhi
    Pak, Terry K.
    Arbour, Kathryn Cecilia
    Lai, Wei-Chu Victoria
    Hellmann, Matthew David
    Riely, Gregory J.
    Kris, Mark G.
    Rudin, Charles M.
    Rekhtman, Natasha
    Li, Bob T.
    Land, Josiah David
    Drilon, Alexander E.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [22] Clinical development of RET inhibitors in RET-rearranged non-small cell lung cancer: Update
    Mendoza, Luis
    ONCOLOGY REVIEWS, 2018, 12 (02) : 69 - 73
  • [23] CABOZANTINIB IS ACTIVE IN PATIENTS WITH ADVANCED RET-REARRANGED NSCLC
    不详
    CANCER DISCOVERY, 2017, 7 (01) : 13 - 13
  • [24] Baseline frequency of brain metastases and outcomes with multikinase inhibitor therapy in patients with RET-rearranged lung cancers.
    Drilon, Alexander E.
    Filleron, Thomas
    Bergagnini, Isabella
    Milia, Julie
    Hatzoglou, Vaios
    Velcheti, Vamsidhar
    Besse, Benjamin
    Mok, Tony
    Awad, Mark M.
    Wolf, Juergen
    Carbone, David P.
    Camidge, D. Ross
    Riely, Gregory J.
    Peled, Nir
    Mazieres, Julien
    Kris, Mark G.
    Gautschi, Oliver
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [25] Phase II study of cabozantinib for patients with advanced RET-rearranged lung cancers.
    Drilon, Alexander E.
    Sima, Camelia S.
    Somwar, Romel
    Smith, Roger
    Ginsberg, Michelle S.
    Riely, Gregory J.
    Rudin, Charles M.
    Ladanyi, Marc
    Kris, Mark G.
    Rizvi, Naiyer A.
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (15)
  • [26] Targeting RET-rearranged non-small-cell lung cancer: future prospects
    Bronte, Giuseppe
    Ulivi, Paola
    Verlicchi, Alberto
    Cravero, Paola
    Delmonte, Angelo
    Crino, Lucio
    LUNG CANCER-TARGETS AND THERAPY, 2019, 10 : 27 - 36
  • [27] Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers
    Hubbeling, H. G.
    Choudhury, N.
    Falcon, C.
    Rusch, V. W.
    Park, B.
    Ziv, E.
    Shaverdian, N.
    Gelblum, D.
    Shepherd, A. F.
    Simone, C. B., II
    Wu, A. J.
    Gomez, D. R.
    Drilon, A.
    Rimner, A.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2021, 111 (03): : E438 - E439
  • [28] Outcomes With Local Therapy and Tyrosine Kinase Inhibition in Patients With ALK/ROS1/RET-Rearranged Lung Cancers
    Hubbeling, Harper
    Choudhury, Noura
    Flynn, Jessica
    Zhang, Zhigang
    Falcon, Christina
    Rusch, Valerie W.
    Park, Bernard J.
    Ziv, Etay
    Shaverdian, Narek
    Gelblum, Daphna Y.
    Shepherd, Annemarie F.
    Simone, Charles B., II
    Wu, Abraham J.
    Gomez, Daniel R.
    Drilon, Alexander
    Rimner, Andreas
    JCO PRECISION ONCOLOGY, 2022, 6
  • [29] Efficacy of first-line treatment options beyond RET-TKIs in advanced RET-rearranged non-small cell lung cancer: A multi-center real-world study
    Ge, Yihui
    Li, Juan
    Gong, Wenjing
    Wang, Jian
    Wei, Xiaojuan
    Liu, Jing
    Wang, Shuyun
    Wang, Leirong
    Sun, Haifeng
    Cheng, Qinglei
    Sun, Yanxin
    Dang, Qi
    Sun, Yuping
    Gao, Aiqin
    CANCER MEDICINE, 2024, 13 (02):
  • [30] Clinical Activity of Alectinib in Advanced RET-Rearranged Non-Small Cell Lung Cancer
    Lin, Jessica J.
    Kennedy, Elizabeth
    Sequist, Lecia V.
    Brastianos, Priscilla K.
    Goodwin, Kelly E.
    Stevens, Sara
    Wanat, Alexandra C.
    Stober, Lisa L.
    Digumarthy, Subba R.
    Engelman, Jeffrey A.
    Shaw, Alice T.
    Gainor, Justin F.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (11) : 2027 - 2032
12345